Last update 24 Apr 2026
Tianjin Eye Hospital

Tianjin Eye Hospital

Hospital|1924|Tianjin Shi, China|
oio.cn

Overview

Tags

Cardiovascular Diseases
Other Diseases
Eye Diseases
Recombinant protein
Protein drugs

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Recombinant protein1
Protein drugs1
Top 5 TargetCount
Akt x PI3Ks1
CXCL14(C-X-C motif chemokine ligand 14)1

Related

2
Drugs associated with Tianjin Eye Hospital
Cocaine and amphetamine-regulated transcript(Nankai University)
Target
Akt x PI3Ks
Mechanism
Akt stimulants [+1]
Active Org.
Tianjin Eye HospitalTianjin Eye Hospital [+1]
Originator Org.-
Active Indication
Myocardial Reperfusion Injury
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
CN118141896
Patent Mining
Target
CXCL14
Mechanism-
Active Org.
Tianjin Eye HospitalTianjin Eye Hospital
Originator Org.
Tianjin Eye HospitalTianjin Eye Hospital
Active Indication
Eye Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
147
Clinical Trials associated with Tianjin Eye Hospital
ChiCTR2600121917
/ Not yet recruitingNot ApplicableIIT
Analysis of the Progression of Posterior Scleral Staphyloma in High Myopia Based on Multimodal Imaging and Construction of a Risk Prediction Model
NCT07518316
/ Not yet recruitingNot ApplicableIIT
Factors Influencing Subjective Visual Quality in Normal Human Eyes and Before and After Refractive Surgery
ChiCTR2600118154
/ Not yet recruitingNot ApplicableIIT
A prospective randomized controlled clinical trial evaluating the adaptability and satisfaction of Stellest® 2.0 lenses and Stellest® frames in myopic children in China
100 Clinical Results associated with Tianjin Eye Hospital
Login to view more data
0 Patents (Medical) associated with Tianjin Eye Hospital
Login to view more data
100 Deals associated with Tianjin Eye Hospital
Login to view more data
100 Translational Medicine associated with Tianjin Eye Hospital
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Cocaine and amphetamine-regulated transcript(Nankai University)
 ( Akt x PI3Ks )		Myocardial Reperfusion Injury
More
Preclinical
CN118141896
 ( CXCL14 )Patent Mining		Eye Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free